Skip to content
Screener

Total Revenue at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$4.98B-9.5%
Stryker logo
StrykerSYK
$6.59B+9.4%
KORU Medical Systems logo
KORU Medical SystemsKRMD
$12.05M+18.2%
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
$1.08B+7.9%
Axogen logo
AxogenAXGN
$69.73M+23.1%
ICU Medical logo
ICU MedicalICUI
$551.68M+0.5%

Segments

By product

See full
Infusion Therapies & Technologies$981M-1.3%
Care & Connectivity Solutions$435M+1.9%
Drug Compounding$320M+30.1%
Advanced Surgery$304M+13.4%
Injectables & Anesthesia$301M-10.1%
Front Line Care$270M-2.5%

By segment

See full
Medical Products & Therapies$1.29B+1.8%
Healthcare Systems & Technologies$705M+0.1%
Pharmaceuticals$621M+6.9%

By geography

See full
International$1.27B

Other financials

Income statement

See full
Gross profit$891.0M+3.5%
Operating income$66.0M+13.8%
Net income-$15.0M-112%
EPS (diluted)-$0.03-112%

Balance sheet

See full
Cash & equivalents$2.0B-12.1%
Total debt$224.0M-8.9%
Total equity$6.0B-14.7%
Total assets$19.8B-6.8%

Cash flow

See full
Operating cash flow$213.0M+210%
CapEx$128.3M+15.0%
Free cash flow$83.0M-42.1%

Valuation

See full
Market cap$14.66B+22.3%
Enterprise value$12.86B+22.1%
P/S1.3×+0.2×

Profitability

See full
Gross margin30.1%-5.9pp
Operating margin-2.7%
Net margin-9.7%+62.5pp
FCF margin3%-2.4pp

Returns & leverage

See full
Return on equity-16.7%-76.7pp
Debt / equity0.0×
Current ratio1.9×-0.2×

Where this comes from

Reported directly by Baxter International in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Baxter International’s 10-Q, filed April 30, 2026.

Filed
Apr 30, 2026, 4:50 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001628280-26-028962
Line itemThree months ended March 31, 2026Three months ended March 31, 2025
Net sales$2,701$2,625
Cost of sales1,8101,764
Gross margin891861
Selling, general and administrative expenses728703
Research and development expenses139140
Other operating income, net(42)(40)
Operating income6658
Interest expense, net6664

Item 1. Financial Statements (unaudited)

FAQ

What is Baxter International's total revenue?
Baxter International (BAX) reported total revenue of $2.7B in Q1 2026.
How has Baxter International's total revenue changed year-over-year?
Baxter International's total revenue increased by 2.9% year-over-year, from $2.63B to $2.7B.
What is the long-term trend for Baxter International's total revenue?
Over 4 years (2021 to 2025), Baxter International's total revenue has grown at a -1.9% compound annual growth rate (CAGR), from $12.15B to $11.24B.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Ask your AI about Baxter International's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude